PDL1+ tumor cells (MDA-MB-231BR cells infected with RRV-miRGFP) in the presence of an anti-PDL1 blocking antibody were unable to suppress CD8+ T cell activation as indicated by the increased frequency of IFNγ+/CD8+ T cells (Figure 6C). This evidence concerns the gene CD8A and neoplasm.